MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617072014 A) filed by Inventage Lab Inc. on June 10, 2026, for Liposome Containing Semaglutide Or Pharmaceutically Acceptable Salt Thereof, Pharmaceutical Composition Comprising Same, And Preparation Method Therefor.
Inventors include Kim, Ju Hee; Lee, Slgirim; and Choe, Hyeongju Number.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to a liposome containing semaglutide or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising same, and a method for preparing same. Semaglutide or a pharmaceutically acceptable salt thereof, which usually exhibits low absorption, can be encapsulated within the liposome, thereby enhancing the absorption rate thereof. In addition, the liposome comprising semaglutide or a pharmaceutically acceptable salt thereof can exhibit excellent effects in regulating blood glucose and preventing and treating obesity by increasing bioavailability. Furthermore, the present invention relates to a method for preparing liposomes containing semaglutide or a pharmaceutically acceptable salt thereof that are uniform in size and exhibit an excellent encapsulation rate and excellent stability.
Disclaimer: Curated by HT Syndication.
